DR
Dayaben Rajeshkumar Desai
About Dayaben Rajeshkumar Desai
Data last updated:
Dayaben Rajeshkumar Desai is a Director at Hanumant Biosciences Private Limited (since 2022). The company operates in FMCG. Hanumant Biosciences Private Limited reported revenue of ₹9.11 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hanumant Biosciences Private Limited U24290GJ2022PTC134320 | Director | 28 Jul 2022 | 2022 | ₹9.11 Cr (FY 2024) | Active |
Board colleagues of Dayaben Rajeshkumar Desai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kashmira Sandipkumar Vaddoriya | 09689095 | Hanumant Biosciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dayaben Rajeshkumar Desai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dayaben Rajeshkumar Desai
Dayaben Rajeshkumar Desai currently holds 1 directorship: Hanumant Biosciences Private Limited (Director, since 28 Jul 2022, revenue ₹9.11 Cr (FY 2024)).
Dayaben Rajeshkumar Desai was first appointed on 28 Jul 2022 as Director at Hanumant Biosciences Private Limited.
The current boards of Dayaben Rajeshkumar Desai's companies include Kashmira Sandipkumar Vaddoriya (Hanumant Biosciences Private Limited).